Here are five details:
1. During the second quarter, the company experienced a 27.7 percent increase in revenue to $15.1 million year-over-year.
2. U.S. revenue for the quarter was $11.5 million, a 24.6 percent increase year-over-year, while international revenue was $3.6 million, a 38.7 percent increase year-over-year.
3. OrthoPediatrics’ trauma and deformity segment generated $9.9 million in revenue, a 25.3 percent increase year-over-year. The company’s scoliosis segment earned $4.9 million in revenue, a 42.7 percent increase year-over-year.
4. The company recorded $11.3 million in gross profit for the quarter, a 29.4 percent increase year-over-year. OrthoPediatrics’ total operating expenses were $13.4 million, a 42.6 percent increase year-over-year.
5. By the end of the year, OrthoPediatrics’ expects its revenue growth to range between 23 percent to 24 percent year-over-year. Prior guidance put revenue growth at 22 percent.
To view the full financial report, click here.
More articles on devices and implants:
Xtant Medical net sales decrease 12.6% in Q2: 5 things to know
Mazor Robotics, Zimmer Biomet, NuVasive & more: 11 device company key notes
ORHub names interim CFO & 5 more mid-year updates
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
